The recent challenges in global distribution have highlighted the value of securing essential medications like Ivermectin. Relying on overseas producers exposes nations to potential vulnerabilities, including transportation delays, price fluctuations, and even political concerns. Transitioning towards domestic production of Ivermectin offers a mult